cve.bz

CVE-2020-10627 insulet omnipod insulin management system firmware: Improper Access Control

8.1 highEPSS 0.5%

High (8.1) in insulet omnipod insulin management system firmware. EPSS 0.5% estimated probability of exploitation activity in the next 30 days.

On this page
Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Manager device. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with access to one of the affected insulin pump models may be able to modify and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.

Severity

CVSS 3.1

8.1 high
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
EPSS
0.5% (unchanged from 0.5% a week ago; 0.5% 30 days ago) estimated probability of exploitation activity in the next 30 days; 43rd percentile. Scored 2026-11-22. A forecast for this CVE across the internet, not for your own systems.
CWE
CWE-284 Improper Access Control
OWASP Top 10
A01:2025 Broken Access Control
Published
Modified
NVD analysis
Analyzed, since modified
Record from
the NVD, synced

Fix and patched versions

Ask an AI about this CVE

Show the promptExplain CVE-2020-10627 for an engineer deciding whether to act. Use https://cve.bz/api/public/cves/CVE-2020-10627?via=ask-ai-copy and https://cve.bz/cve/CVE-2020-10627?via=ask-ai-copy as the source of truth: what is affected and which versions fix it, whether it is in CISA KEV, public exploits, and its EPSS (an internet-wide 30-day estimate of exploitation activity, not a forecast for my systems). If they give no fixed versions, use the CVE record https://cveawg.mitre.org/api/cve/CVE-2020-10627 or the vendor advisory, not third-party mirrors. Tell me how to check whether I am affected and how to verify a fix. Cite the sources and say where they are uncertain.

Opens a third-party assistant; its answer is its own, not cve.bz's. The prompt holds only this CVE's id and public links.

Affected

Versions

From the CNA's record in the CVE List.

ProductAffected
Insulet Omnipod Insulin Management System19191
Insulet Omnipod Insulin Management System40160
Insulet Omnipod Insulin Management SystemZXP425
Insulet Omnipod Insulin Management SystemZXR425

ICS advisories (CISA)

AdvisoryTitlePublishedSectorsAffectedFixed
ICSMA-20-079-01Insulet Omnipod2020-03-19Healthcare and Public HealthOmnipod Insulin Management System: UDI/Model/NDC number ZXP425 (10-Pack) and ZXR425 (10-Pack Canada), Omnipod Insulin Management System: Product ID/Reorder number 19191 and 40160none listed

From CISA's ICS advisories (CSAF), provided under CISA's notification. Only the facts are shown; each advisory is on CISA's page. Credits.

Attack patterns (CAPEC)

The attack patterns MITRE's CAPEC relates to this record's weaknesses, as MITRE names them. Credits. More on the page of CWE-284 (17).

References

Check your stackJSON